NO142669C - Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser

Info

Publication number
NO142669C
NO142669C NO744615A NO744615A NO142669C NO 142669 C NO142669 C NO 142669C NO 744615 A NO744615 A NO 744615A NO 744615 A NO744615 A NO 744615A NO 142669 C NO142669 C NO 142669C
Authority
NO
Norway
Prior art keywords
preparation
heterocyclic compounds
therapeutic active
analogy procedure
analogy
Prior art date
Application number
NO744615A
Other languages
English (en)
Norwegian (no)
Other versions
NO744615L (de
NO142669B (no
Inventor
Henri Ramuz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO744615L publication Critical patent/NO744615L/no
Priority to NO752888A priority Critical patent/NO752888L/no
Publication of NO142669B publication Critical patent/NO142669B/no
Publication of NO142669C publication Critical patent/NO142669C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO744615A 1973-12-21 1974-12-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser NO142669C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO752888A NO752888L (de) 1973-12-21 1975-08-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1803073A CH611614A5 (en) 1973-12-21 1973-12-21 Process for the preparation of heterocyclic compounds

Publications (3)

Publication Number Publication Date
NO744615L NO744615L (de) 1975-07-21
NO142669B NO142669B (no) 1980-06-16
NO142669C true NO142669C (no) 1980-09-24

Family

ID=4429892

Family Applications (1)

Application Number Title Priority Date Filing Date
NO744615A NO142669C (no) 1973-12-21 1974-12-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser

Country Status (24)

Country Link
JP (1) JPS595594B2 (de)
AT (5) AT344693B (de)
AU (1) AU511714B2 (de)
BE (1) BE823625A (de)
CA (4) CA1057295A (de)
CH (3) CH611614A5 (de)
DD (1) DD116829A5 (de)
DE (2) DE2463173C2 (de)
DK (1) DK148323C (de)
ES (5) ES433172A1 (de)
FI (1) FI67216C (de)
FR (1) FR2255064B1 (de)
GB (3) GB1489088A (de)
HK (1) HK43380A (de)
HU (1) HU170429B (de)
IE (1) IE40788B1 (de)
IL (3) IL46146A (de)
LU (1) LU71530A1 (de)
NL (1) NL158496B (de)
NO (1) NO142669C (de)
PH (3) PH19393A (de)
SE (2) SE415763B (de)
YU (1) YU39311B (de)
ZA (1) ZA747526B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515173A1 (fr) * 1981-10-28 1983-04-29 Delalande Sa Nouveaux derives du benzaldehyde 3-4-diethere et leur procede de preparation
JPS60142297U (ja) * 1984-02-29 1985-09-20 株式会社豊田自動織機製作所 フオ−クリフトにおける旋回型運転席の回転装置
JPS62171328U (de) * 1986-04-23 1987-10-30
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
US5434179A (en) * 1989-06-06 1995-07-18 Takeda Chemical Industries, Ltd. Method for improving brain function using cholinesterase-inhibiting aminoketone compounds
MXPA04006344A (es) * 2001-12-28 2005-03-31 Takeda Pharmaceutical Preventivos/remedios para la perturbacion de miccion.
WO2010006103A1 (en) * 2008-07-10 2010-01-14 Ore Pharmaceuticals Inc. Method for enhancing cognition or inhibiting cognitive decline

Also Published As

Publication number Publication date
DE2463173C2 (de) 1987-01-29
IL52843A0 (en) 1977-10-31
GB1489086A (en) 1977-10-19
PH13396A (en) 1980-03-28
CH611614A5 (en) 1979-06-15
HK43380A (en) 1980-08-22
CA1079290A (en) 1980-06-10
IE40788L (en) 1975-06-21
CA1072966A (en) 1980-03-04
SE434746B (sv) 1984-08-13
AT350053B (de) 1979-05-10
ES451137A1 (es) 1977-08-16
NL7416507A (nl) 1975-06-24
ES451135A1 (es) 1977-08-16
DE2460593A1 (de) 1975-07-03
ZA747526B (en) 1975-12-31
GB1489088A (en) 1977-10-19
ES451136A1 (es) 1977-10-01
ATA38778A (de) 1978-08-15
YU39311B (en) 1984-10-31
DD116829A5 (de) 1975-12-12
NO744615L (de) 1975-07-21
HU170429B (de) 1977-06-28
DE2460593C3 (de) 1979-09-13
FR2255064B1 (de) 1978-03-24
ES451134A1 (es) 1977-08-16
IL52844A0 (en) 1977-10-31
PH13326A (en) 1980-03-13
DK668174A (de) 1975-08-25
AU7600874A (en) 1976-06-03
DE2460593B2 (de) 1979-01-18
FR2255064A1 (de) 1975-07-18
AT344693B (de) 1978-08-10
CA1057295A (en) 1979-06-26
FI352774A (de) 1975-06-22
ATA39178A (de) 1978-08-15
PH19393A (en) 1986-04-07
NO142669B (no) 1980-06-16
BE823625A (fr) 1975-06-20
YU336874A (en) 1982-05-31
AU511714B2 (en) 1980-09-04
IE40788B1 (en) 1979-08-15
IL46146A (en) 1980-09-16
DK148323B (da) 1985-06-10
FI67216C (fi) 1985-02-11
DK148323C (da) 1986-03-03
ATA38878A (de) 1978-08-15
JPS5095267A (de) 1975-07-29
AT349013B (de) 1979-03-12
AT349014B (de) 1979-03-12
NL158496B (nl) 1978-11-15
SE415763B (sv) 1980-10-27
GB1489087A (en) 1977-10-19
AT349012B (de) 1979-03-12
AU3224278A (en) 1978-05-25
CH620921A5 (en) 1980-12-31
JPS595594B2 (ja) 1984-02-06
FI67216B (fi) 1984-10-31
SE7416086L (de) 1975-06-23
IL46146A0 (en) 1975-03-13
ATA38978A (de) 1978-10-15
ATA1022674A (de) 1977-12-15
LU71530A1 (de) 1976-11-11
CA1086320A (en) 1980-09-23
CH620920A5 (en) 1980-12-31
ES433172A1 (es) 1977-04-16

Similar Documents

Publication Publication Date Title
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO143576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
NO144885C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater
NO142304C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)-isokinolin-derivater
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
NO141687C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-oxo-2,2-disubstituerte-5-indanyloxy-eddiksyrer
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO146396C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO143846C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater
NO143223C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO141649C (no) Analogifremgangsmaate for fremstilling av neuroleptisk aktive 7-fluorsubstituerte fenotiaziner
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
NO142669C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser
NO144457C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner
SE7608958L (sv) Forfarande for framstellning av 2-(fenoxialkyl-sulfinyl eller -sulfonyl) imidazoler
NO142077C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider
NO141441C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on
NO144110C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater